White matter lesions in patients with localization-related epilepsy

Investigative Radiology

Volumn 43, Issue 8, 2008, Pages 552-558

  Jansen, Jacobus F A ^a,b   Vlooswijk, Marielle C G ^a   Majoie, Hj Marian ^a,b   De Krom, Marc C T F M ^a   Aldenkamp, Albert P ^a,b   Hofman, Paul A M ^a   Backes, Walter H ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

Author keywords

Cognitive decline; Epilepsy; Fluid attenuated inversion recovery; White matter lesions

Indexed keywords

ADULT; ARTICLE; BRAIN DAMAGE; COGNITION; CONTROLLED STUDY; FEMALE; FOCAL EPILEPSY; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; ALGORITHM; COGNITIVE DEFECT; IMAGE PROCESSING; MIDDLE AGED;

ADULT; ALGORITHMS; COGNITION DISORDERS; EPILEPSIES, PARTIAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 49849085688     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e31817e90d2     Document Type: Article

References (48)

1. Ovbiagele B, Saver JL. Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications. Cerebrovasc Dis. 2006; 22:83-90.
2. Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology. 2000;14:224-232.
3. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry. 2000;57:1071-1076.
4. De Groot JC, De Leeuw FE, Oudkerk M, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol. 2002;52:335-341.
5. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol. 2000;47:145-151.
6. Pantoni L, Leys D, Fazekas F, et al. Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer Dis Assoc Disord. 1999;13(suppl 3):S49-S54.
7. Dikmen S, Matthews CG. Effect of major motor seizure frequency upon cognitive-intellectual functions in adults. Epilepsia. 1977;18:21-29.
8. Dodrill CB. Correlates of generalized tonic-clonic seizures with intellectual, neuropsychological, emotional, and social function in patients with epilepsy. Epilepsia. 1986;27:399-411.
9. Jokeit H, Schacher M. Neuropsychological aspects of type of epilepsy and etiological factors in adults. Epilepsy Behav. 2004;5(suppl 1):S14-S20.
10. Oyegbile TO, Dow C, Jones J, et al. The nature and course of neuropsychological morbidity in chronic temporal lobe epilepsy. Neurology. 2004;62:1736-1742.
11. Hopkins RO, Beck CJ, Burnett DL, et al. Prevalence of white matter hyperintensities in a young healthy population. J Neuroimaging. 2006; 16:243-251.
12. Wieshmann UC. Clinical application of neuroimaging in epilepsy. J Neurol Neurosurg Psychiatr. 2003;74:466-470.
13. Sanders WP, Silbergleit R, Spickler EM, et al. Efficacy of gadolinium administration in magnetic resonance imaging screening of patients with complex partial seizures and results of a normal neurologic examination. Invest Radiol. 1995;30:634-637.
14. Eriksson SH, Stepney A, Symms MR, et al. Ultra-fast low-angle rapid acquisition and relaxation enhancement (UFLARE) in patients with epilepsy. Neuroradiology. 2001;43:1040-1045.
15. Nielsen K, Rostrup E, Frederiksen JL, et al. Magnetic resonance imaging at 3. 0 Tesla detects more lesions in acute optic neuritis than at 1.5 Tesla. Invest Radiol. 2006;41:76-82.
16. Frayne R, Goodyear BG, Dickhoff P, et al. Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol. 2003;38:385-402.
17. Bachmann R, Reilmann R, Schwindt W, et al. FLAIR imaging for multiple sclerosis: a comparative MR study at 1.5 and 3.0 Tesla. Eur Radiol. 2006;16:915-921.
18. Sicotte NL, Voskuhl RR, Bouvier S, et al. Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla. Invest Radiol. 2003;38:423-427.
19. Wattjes MP, Lutterbey GG, Harzheim M, et al. Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T. Eur Radiol. 2006; 16:2067-2073.
20. Lammers MW, Hekster YA, Keyser A, et al. Monotherapy or polytherapy for epilepsy revisited: a quantitative assessment. Epilepsia. 1995; 36:440-446.
21. Wechsler D. Wechsler Adult Intelligence Scale. 3rd ed. San Antonio, TX: The Psychological Corporation; 1997.
22. Lange RT, Chelune GJ. Application of new WAIS-III/WMS-III discrepancy scores for evaluating memory functioning: relationship between intellectual and memory ability. J Clin Exp Neuropsychol. 2006;28:592-ions.
23. Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol. 2000;12:191-200.
24. Achten E, Breteler MM, De Leeuw FE, et al. A rating scale for age related brain changes. The Rotterdam Scan Study. Imaging Decis MRI. 2000;l:10-19.
25. Henskens LH, Kroon AA, van Boxtel MP, et al. Associations of the angiotensin II type 1 receptor Al 166C and the endothelial NO synthase G894T gene polymorphisms with silent subcortical white matter lesions in essential hypertension. Stroke. 2005;36:1869-1873.
26. van Boxtel MP, Henskens LH, Kroon AA, et al. Ambulatory blood pressure, asymptomatic cerebrovascular damage and cognitive function in essential hypertension. J Hum Hypertens. 2006;20:5-13.
27. Gronenschild E. GIANT [computer program]. Version 1v1.2. Maastricht, The Netherlands: Maastricht University; 2006.
28. Jansen JF, Kooi ME, Kessels AG, et al. Reproducibility of quantitative cerebral T2 relaxometry, diffusion tensor imaging, and 1H magnetic resonance spectroscopy at 3.0 Tesla. Invest Radiol. 2007;42:327-337.
29. Woermann FG, Barker GJ, Birnie KD, et al. Regional changes in hippocampal T2 relaxation and volume: a quantitative magnetic resonance imaging study of hippocampal sclerosis. J Neurol Neurosurg Psychiatr. 1998;65:656-664.
30. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17:143-155.
31. Maldjian JA, Laurienti PJ, Kraft RA, et al. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage. 2003;19:1233-1239.
32. Langers DR, Jansen JF, Backes WH. Enhanced signal detection in neuroimaging by means of regional control of the global false discovery rate. Neuroimage. 2007;38:43-56.
33. Tofts P. Quantitative MRI of the Brain Measuring Changes Caused by Disease. Hoboken, NJ: John Wiley & Sons Ltd.; 2003.
34. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988;75:800-802.
35. Moon WK, Chang KH, Cho SY, et al. Cerebral sparganosis: MR imaging versus CT features. Radiology. 1993;188:751-757.
36. De Reuck J, Decoo D, Boon P, et al. Late-onset epileptic seizures in patients with leukoaraiosis: a positron emission tomographic study. Eur Neurol. 1996;36:20-24.
37. Awada A, Omojola MF, Obeid T. Late epileptic seizures after cerebral infarction. Acta Neurol Scand. 1999;99:265-268.
38. Paradowski B, Zagrajek MM. Epilepsy in middle-aged and elderly people: a three-year observation. Epileptic Disord. 2005;7:91-95.
39. Admiraal-Behloul F, van den Heuvel DM, Olofsen H, et al. Fully automatic segmentation of white matter hyperintensities in MR images of the elderly. Neuroimage. 2005;28:607-617.
40. Wu M, Rosano C, Butters M, et al. A fully automated method for quantifying and localizing white matter hyperintensities on MR images. Psychiatry Res. 2006;148:133-142.
41. Yoshita M, Fletcher E, DeCarli C. Current concepts of analysis of cerebral white matter hyperintensities on magnetic resonance imaging. Top Magn Reson Imaging. 2005;16:399-407.
42. Hirono N, Kitagaki H, Kazui H, et al. Impact of white matter changes on clinical manifestation of Alzheimer's disease: a quantitative study. Stroke. 2000;31:2182-2188.
43. Jack CR Jr, O'Brien PC, Rettman DW, et al. FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging. 2001;14:668-676.
44. Wen W, Sachdev P. The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year-old individuals. Neuroimage. 2004;22:144-154.
45. Swartz RH, Black SE, Feinstein A, et al. Utility of simultaneous brain, CSF and hyperintensity quantification in dementia. Psychiatry Res. 2002;l 16:83-93.
46. DeCarli C, Fletcher E, Ramey V, et al. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke. 2005;36:50-55.
47. Wu Y, Warfield SK, Tan IL, et al. Automated segmentation of multiple sclerosis lesion subtypes with multichannel MRI. Neuroimage. 2006;32: 1205-1215.
48. Chagla GH, Busse RF, Sydnor R, et al. 3D FLAIR imaging with isotropic resolution and nonselective adiabatic inversion provides 3D display and improved CSF suppression compared to 2D FLAIR at 3 Tesla. Invest Radiol. 2008;43:547-551.